Intellia Therapeutics
NTLA
NTLA
156 hedge funds and large institutions have $789M invested in Intellia Therapeutics in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 55 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
+26
Holders Change %
+20%
% of All Funds
3.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
40
Increased
55
Reduced
29
Closed
13
Calls
$7.78M
Puts
$6.72M
Net Calls
+$1.06M
Net Calls Change
+$6.42M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$73.8M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$123M |
| 3 |
BlackRock
New York
|
$69.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$64.7M |
| 5 |
Morgan Stanley
New York
|
$61.1M |
